MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection, is broadening its platform with a new fatigue prediction model designed for high-risk workplace environments. The development, detailed in a recent article, represents a strategic expansion of the company's voice analytics capabilities.
The fatigue detection capability is expected to become an additional feature within MindBio's planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of alcohol, drug impairment and fatigue from short voice samples. The company's platform analyzes speech characteristics captured through a microphone and processes the audio using machine learning models trained on large voice datasets, offering a scalable alternative to conventional impairment screening methods such as breathalyzers, saliva tests, urine analysis and laboratory-based toxicology testing.
MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
The addition of fatigue detection positions MindBio to address a critical safety issue in high-risk industries, where fatigued workers can pose significant dangers. This move reflects a broader strategy by MindBio to position voice analytics as a versatile tool for workplace safety, potentially reducing reliance on traditional testing methods that require physical samples and laboratory analysis.
For more details, the full article is available at https://nnw.fm/5DDUT. The latest news and updates relating to MBQIF are available in the company's newsroom at https://nnw.fm/MBQIF.
